July 31 (Reuters) - European chemicals maker dsm-firmenich DSFIR.AS on Thursday reported second-quarter core profit above market expectations, citing good organic growth, synergies and the group's vitamin transformation program
The group's adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) came in at 610 million euros ($697 million), beating analysts' forecast of 513 million euros in a company-provided consensus.
($1 = 0.8747 euros)
(Reporting by Dimitri Rhodes)
((Dimitri.Rhodes@thomsonreuters.com;))